首页 | 本学科首页   官方微博 | 高级检索  
     


Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial
Authors:Ingemar S. J. Merkies  John‐Philip Lawo  Jonathan M. Edelman  Jan L. De Bleecker  Claudia Sommer  Wim Robberecht  Mika Saarela  Jerzy Kamienowski  Zbigniew Stelmasiak  Orell Mielke  Bj?rn Tackenberg  Jean‐Marc Léger
Affiliation:1. Spaarne Hospital, Hoofddorp, and Maastricht University Medical Centre, Maastricht, The Netherlands;2. CSL Behring GmbH, Marburg, Germany;3. CSL Behring LLC, King of Prussia, PA, USA;4. AZ St‐Lucas, Gent, Belgium;5. Department of Neurology, Universit?tsklinikum Würzburg, Würzburg, Germany;6. UZ Leuven, Leuven, Belgium;7. Department of Neurology, Helsinki University Central Hospital, Helsinki, Finland;8. Dolno?l?ski Szpital Specjalistyczny, Wroclaw, Poland;9. Samodzielny Publiczny Szpital Kliniczny, Lublin, Poland;10. Department of Neurology, Philipps University, Marburg, Germany;11. Reference Center for Rare Neuromuscular Diseases, H?pital Pitié‐Salpêtrière, and University Paris VI, Paris, France
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号